Menu ×

HEALTHCARE & PHARMACEUTICAL

Intracranial Abscess Treatment Market Segmentation by Origin (Ear Infection, Chronic Sinusitis, Neurosurgery, Head Injury, and Others); by Diagnosis (MRI, CT scan, and Others); by Treatment (Antibiotic Therapy, Surgery, and Others); by End-User (Hospital, Specialty Clinic, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Intracranial Abscess Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Global Intracranial Abscess Treatment Market Highlights over 2022 – 2030

The global intracranial abscess treatment market is estimated to grow at a CAGR of ~18% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the increasing prevalence of intracranial abscess, backed by increasing head injuries, and neurosurgeries. Intracranial abscess refers to collection of pus between the brain and skull. This blocks the flow of blood to the brain, which, in turn, limits the supply of oxygen to that part of the brain, resulting to impairment of speech and hearing, coordination and movement troubles, disturbed consciousness, and even paralysis. The pus is generated when any infection reaches the brain, which can be through ear, teeth, throat, or directly through head during a surgery. The rising cases of road accidents, that cause head injuries, and as a result, require a surgery, are estimated to drive the market growth. According to the data by the World Health Organization (WHO), between 20 and 50 million people suffer non-fatal injuries in road accidents. The mounting prevalence of cerebrovascular diseases, and neurological diseases, such as, Parkinson’s disease, dementia, cerebral infarction, and others, is also projected to boost the market growth.

Intracranial Abscess Treatment Market Graph

The market is segmented by origin into ear infection, chronic sinusitis, neurosurgery, head injury, and others, out of which, the head injury segment is anticipated to hold the notable share in the global intracranial abscess treatment market over the forecast period on account of rising cases of severe head injuries, most of which are caused in road accidents, falls, or other traumatic accidents. Mostly, these injuries become the source of infection inside the skull, which, as a result, cause intracranial abscess. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Intracranial Abscess Treatment Market Regional Synopsis

On the basis of geographical analysis, the global intracranial abscess treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of high cases of injuries, and accidents, along with growing healthcare system in the developing countries.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period high healthcare expenditure, and presence of major pharmaceutical companies. According to the statistics by the World Bank, the total healthcare expenditure of North America accounted for 16.415% of the total GDP, in 2018. Increasing research activities for the development of new drugs is also estimated to boost the market growth.

Intracranial Abscess Treatment Market Share Graph

The global intracranial abscess treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global intracranial abscess treatment market includes the following segments:

By Origin

  • Ear Infection
  • Chronic Sinusitis
  • Neurosurgery 
  • Head Injury
  • Others

By Diagnosis

  • MRI
  • CT scan
  • Others

By Treatment

  • Antibiotic Therapy
  • Surgery
  • Others

By End-User

  • Hospital

  • Specialty Clinic
  • Others

Growth Drivers

  • Rising Cases of Head Injuries
  • Increasing Medical R&D Activities

Challenges

  • Complications Associated with the Surgery
  • Difficult Diagnosis of the Disease

Top Featured Companies Dominating the Market

  • Alembic Limited
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Eli Lilly and Company
  • Hindustan Antibiotics Limited
  • Sun Pharmaceutical Industries Ltd.
  • Novartis AG
  • Sanofi-aventis Groupe
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Siemens Healthcare GmbH
  • Pfizer Inc.

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved